These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 19107340)

  • 21. Impact of microvessel density on lymph node metastasis and survival after curative resection of pancreatic cancer.
    Benckert C; Thelen A; Cramer T; Weichert W; Gaebelein G; Gessner R; Jonas S
    Surg Today; 2012 Jan; 42(2):169-76. PubMed ID: 22068680
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Aggressive surgical resection for hilar-invasive and peripheral intrahepatic cholangiocarcinoma.
    Nakagohri T; Asano T; Kinoshita H; Kenmochi T; Urashima T; Miura F; Ochiai T
    World J Surg; 2003 Mar; 27(3):289-93. PubMed ID: 12607053
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunohistochemically demonstrated lymph node micrometastasis and prognosis in patients with otherwise node-negative hilar cholangiocarcinoma.
    Tojima Y; Nagino M; Ebata T; Uesaka K; Kamiya J; Nimura Y
    Ann Surg; 2003 Feb; 237(2):201-7. PubMed ID: 12560778
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The prognosis and survival outcome of intrahepatic cholangiocarcinoma following surgical resection: association of lymph node metastasis and lymph node dissection with survival.
    Choi SB; Kim KS; Choi JY; Park SW; Choi JS; Lee WJ; Chung JB
    Ann Surg Oncol; 2009 Nov; 16(11):3048-56. PubMed ID: 19626372
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oncological superiority of hilar en bloc resection for the treatment of hilar cholangiocarcinoma.
    Neuhaus P; Thelen A; Jonas S; Puhl G; Denecke T; Veltzke-Schlieker W; Seehofer D
    Ann Surg Oncol; 2012 May; 19(5):1602-8. PubMed ID: 21964888
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tumor angiogenesis as a prognostic factor in oral cavity carcinomas.
    López-Graniel CM; Tamez de León D; Meneses-García A; Gómez-Ruiz C; Frias-Mendivil M; Granados-García M; Barrera-Franco JL
    J Exp Clin Cancer Res; 2001 Dec; 20(4):463-8. PubMed ID: 11876537
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intrahepatic cholangiocarcinoma: rising frequency, improved survival, and determinants of outcome after resection.
    Endo I; Gonen M; Yopp AC; Dalal KM; Zhou Q; Klimstra D; D'Angelica M; DeMatteo RP; Fong Y; Schwartz L; Kemeny N; O'Reilly E; Abou-Alfa GK; Shimada H; Blumgart LH; Jarnagin WR
    Ann Surg; 2008 Jul; 248(1):84-96. PubMed ID: 18580211
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Surgical outcomes of 230 resected hilar cholangiocarcinoma in a single centre.
    Song SC; Choi DW; Kow AW; Choi SH; Heo JS; Kim WS; Kim MJ
    ANZ J Surg; 2013 Apr; 83(4):268-74. PubMed ID: 22943422
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Predictive factors of early recurrence after R0 resection of hilar cholangiocarcinoma: A single institution experience in China.
    Hu HJ; Jin YW; Shrestha A; Ma WJ; Wang JK; Liu F; Zhu YY; Zhou RX; Regmi P; Cheng NS; Li FY
    Cancer Med; 2019 Apr; 8(4):1567-1575. PubMed ID: 30868740
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Angiogenesis in cholangiocellular carcinoma: expression of vascular endothelial growth factor, angiopoietin-1/2, thrombospondin-1 and clinicopathological significance.
    Tang D; Nagano H; Yamamoto H; Wada H; Nakamura M; Kondo M; Ota H; Yoshioka S; Kato H; Damdinsuren B; Marubashi S; Miyamoto A; Takeda Y; Umeshita K; Dono K; Wakasa K; Monden M
    Oncol Rep; 2006 Mar; 15(3):525-32. PubMed ID: 16465407
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Assessment of nodal status for perihilar cholangiocarcinoma: location, number, or ratio of involved nodes.
    Aoba T; Ebata T; Yokoyama Y; Igami T; Sugawara G; Takahashi Y; Nimura Y; Nagino M
    Ann Surg; 2013 Apr; 257(4):718-25. PubMed ID: 23407295
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recurrences in stage II rectal carcinoma after curative resection alone: from the viewpoint of angiogenesis.
    Martinović Ž; Kovač D; Martinović C
    World J Surg Oncol; 2016 Apr; 14():122. PubMed ID: 27102733
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The impact of portal vein resection on outcomes for hilar cholangiocarcinoma: a multi-institutional analysis of 305 cases.
    de Jong MC; Marques H; Clary BM; Bauer TW; Marsh JW; Ribero D; Majno P; Hatzaras I; Walters DM; Barbas AS; Mega R; Schulick RD; Choti MA; Geller DA; Barroso E; Mentha G; Capussotti L; Pawlik TM
    Cancer; 2012 Oct; 118(19):4737-47. PubMed ID: 22415526
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic value of lymphadenectomy for long-term outcomes in node-negative intrahepatic cholangiocarcinoma: A multicenter study.
    Yoh T; Cauchy F; Le Roy B; Seo S; Taura K; Hobeika C; Dokmak S; Farges O; Gelli M; Sa Cunha A; Adam R; Uemoto S; Soubrane O
    Surgery; 2019 Dec; 166(6):975-982. PubMed ID: 31421869
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Perioperative and long-term outcome of intrahepatic cholangiocarcinoma involving the hepatic hilus after curative-intent resection: comparison with peripheral intrahepatic cholangiocarcinoma and hilar cholangiocarcinoma.
    Zhang XF; Bagante F; Chen Q; Beal EW; Lv Y; Weiss M; Popescu I; Marques HP; Aldrighetti L; Maithel SK; Pulitano C; Bauer TW; Shen F; Poultsides GA; Soubrane O; Martel G; Koerkamp BG; Guglielmi A; Itaru E; Pawlik TM
    Surgery; 2018 May; 163(5):1114-1120. PubMed ID: 29398035
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical significance of preoperative CA19-9 and lymph node metastasis in intrahepatic cholangiocarcinoma.
    Asaoka T; Kobayashi S; Hanaki T; Iwagami Y; Tomimaru Y; Akita H; Noda T; Gotoh K; Takeda Y; Tanemura M; Doki Y; Eguchi H
    Surg Today; 2020 Oct; 50(10):1176-1186. PubMed ID: 32221659
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of specialized multi-disciplinary approach and an integrated pathway on outcomes in hilar cholangiocarcinoma.
    Gomez D; Patel PB; Lacasia-Purroy C; Byrne C; Sturgess RP; Palmer D; Fenwick S; Poston GJ; Malik HZ
    Eur J Surg Oncol; 2014 Jan; 40(1):77-84. PubMed ID: 24262111
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term outcome and prognostic factors of intrahepatic cholangiocarcinoma involving the hepatic hilus versus hilar cholangiocarcinoma after curative-intent resection: Should they be recognized as perihilar cholangiocarcinoma or differentiated?
    Lu J; Li B; Li FY; Ye H; Xiong XZ; Cheng NS
    Eur J Surg Oncol; 2019 Nov; 45(11):2173-2179. PubMed ID: 31208772
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Invasion category-oriented lymph node metastases of cholangiocarcinoma and the prognostic impact.
    Kobayashi S; Wada H; Tomokuni A; Takahashi H; Gotoh K; Sakon M; Mori M; Doki Y; Eguchi H
    Langenbecks Arch Surg; 2020 Nov; 405(7):989-998. PubMed ID: 32812064
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Major hepatectomy for hilar cholangiocarcinoma type 3 and 4: prognostic factors and longterm outcomes.
    Baton O; Azoulay D; Adam DV; Castaing D
    J Am Coll Surg; 2007 Feb; 204(2):250-60. PubMed ID: 17254929
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.